Targeting mitochondrial dysfunction: an innovative strategy for treating renal fibrosis
Authors:
- 29 April 2025
- journal article
- review article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- p. 1-18
Abstract
The incidence and hospitalization rate of kidney disease, especially end-stage renal disease, have increased significantly, which seriously endangers the health of patients. Mitochondria are the core organelles of cellular energy metabolism, and their dysfunction can lead to kidney energy supply insufficiency and oxidative stress damage, which has become a global public health problem. Studies have shown that the disturbance of mitochondrial quality control mechanisms, including mitochondrial dynamics, autophagy, oxidative stress regulation and biosynthesis, is closely related to the occurrence and development of renal fibrosis (RF). As a multicellular pathological process, RF involves the injury and shedding of podocytes, the transdifferentiation of renal tubular epithelial cells, the activation of fibroblasts, and the infiltration of macrophages, among which the mitochondrial dysfunction plays an important role. This review systematically elaborates the molecular mechanisms of mitochondrial damage during RF progression, aiming to provide theoretical foundations for developing novel therapeutic strategies to delay RF advancement.Keywords
Funding Information
- 111 Project of the National Ministry of Education (B18035)
- the Fundamental Research Funds for the Central Universities
This publication has 148 references indexed in Scilit:
- Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial FunctionCell Biochemistry and Biophysics, 2023
- Small Ceria Nanoclusters with High ROS Scavenging Activity and Favorable Pharmacokinetic Parameters for the Amelioration of Chronic Kidney DiseaseAdvanced Healthcare Materials, 2023
- Chronic kidney disease–associated pruritus: what is known and its application in childrenPediatric Nephrology, 2023
- Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillanceAngiogenesis, 2022
- Therapeutic and delivery strategies of phytoconstituents for renal fibrosisAdvanced Drug Delivery Reviews, 2021
- Mitochondrial Transfer from Mesenchymal Stem Cells to Macrophages Restricts Inflammation and Alleviates Kidney Injury in Diabetic Nephropathy Mice via PGC-1α ActivationStem Cells, 2021
- The CKD-MBD Syndrome: Hysteresis in PTH Involvement and PTH Administration for Its ManagementJournal of Bone and Mineral Research, 2020
- A more tubulocentric view of diabetic kidney diseaseJournal Of Nephrology, 2017
- Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or PioglitazoneJAMA, 2010
- The mitochondrial antioxidant defence system and its response to oxidative stressProteomics, 2001